National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 526572

History of Changes from the VAERS Wayback Machine

First Appeared on 4/14/2014

526572
VAERS Form:
Age:16.0
Gender:Female
Location:Michigan
Vaccinated:2011-08-30
Onset:2011-09-10
Submitted:2014-03-25
Entered:2014-03-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / - UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Coeliac disease, Fatigue, Gait disturbance, Muscular weakness, Myalgia, Myasthenia gravis, Immunoglobulin therapy

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES1403USA010855

Write-up:This spontaneous report as received from a physician refers to a 16 year old female patient. On 30-AUG-2011 the patient was vaccinated with GARDASIL, 0.5 ml, intramuscular. The dose number, the lot number and expiration date of the vaccine, the route of administration and anatomical location of the vaccination were not reported. On 10-SEP-2011, reported as 11 days after the date of vaccination the patient experienced celiac disease (disability, medically significant upon internal review), tripping down the stairs because her legs were so weak (disability), muscle pain (disability), extreme fatigue (disability), myasthenia gravis (disability, medically significant upon internal review) and being so weak that she had issue lifting her arms (disability). Disability was reported as serious criterion, the event(s) to which this referred however were not specified. Treatment for the myasthenia gravis included MESTINON, IVIG and Prednisone. The outcome of celiac disease, tripping down the stairs, muscle pain, extreme fatigue and myasthenia gravis was reported as not recovered/not resolved. The physician reported that all adverse effects were progressing. No causality statement was reported for any of the events in relation to GARDASIL. Additional information has been requested.


Changed on 6/14/2014

526572 Before After
VAERS Form:
Age:16.0
Gender:Female
Location:Michigan
Vaccinated:2011-08-30
Onset:2011-09-10
Submitted:2014-03-25
Entered:2014-03-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / - UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Coeliac disease, Fatigue, Gait disturbance, Muscular weakness, Myalgia, Myasthenia gravis, Immunoglobulin therapy

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES1403USA010855

Write-up:This spontaneous report as received from a physician refers to a 16 year old female patient. On 30-AUG-2011 the patient was vaccinated with GARDASIL, 0.5 ml, intramuscular. The dose number, the lot number and expiration date of the vaccine, the route of administration and anatomical location of the vaccination were not reported. On 10-SEP-2011, reported as 11 days after the date of vaccination the patient experienced celiac disease (disability, medically significant upon internal review), tripping down the stairs because her legs were so weak (disability), muscle pain (disability), extreme fatigue (disability), myasthenia gravis (disability, medically significant upon internal review) and being so weak that she had issue lifting her arms (disability). Disability was reported as serious criterion, the event(s) to which this referred however were not specified. Treatment for the myasthenia gravis included MESTINON, IVIG and Prednisone. The outcome of celiac disease, tripping down the stairs, muscle pain, extreme fatigue and myasthenia gravis was reported as not recovered/not resolved. The physician reported that all adverse effects were progressing. No causality statement was reported for any of the events in relation to GARDASIL. Additional information has been requested.


Changed on 3/14/2015

526572 Before After
VAERS Form:
Age:16.0
Gender:Female
Location:Michigan
Vaccinated:2011-08-30
Onset:2011-09-10
Submitted:2014-03-25
Entered:2014-03-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / - UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Coeliac disease, Fatigue, Gait disturbance, Muscular weakness, Myalgia, Myasthenia gravis, Immunoglobulin therapy

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES1403USA010855

Write-up:This spontaneous report as received from a physician refers to a 16 year old female patient. On 30-AUG-2011 the patient was vaccinated with GARDASIL, 0.5 ml, intramuscular. The dose number, the lot number and expiration date of the vaccine, the route of administration and anatomical location of the vaccination were not reported. On 10-SEP-2011, reported as 11 days after the date of vaccination the patient experienced celiac disease (disability, medically significant upon internal review), tripping down the stairs because her legs were so weak (disability), muscle pain (disability), extreme fatigue (disability), myasthenia gravis (disability, medically significant upon internal review) and being so weak that she had issue lifting her arms (disability). Disability was reported as serious criterion, the event(s) to which this referred however were not specified. Treatment for the myasthenia gravis included MESTINON, IVIG and Prednisone. The outcome of celiac disease, tripping down the stairs, muscle pain, extreme fatigue and myasthenia gravis was reported as not recovered/not resolved. The physician reported that all adverse effects were progressing. No causality statement was reported for any of the events in relation to GARDASIL. Additional information has been requested.


Changed on 9/14/2017

526572 Before After
VAERS Form:(blank) 1
Age:16.0
Gender:Female
Location:Michigan
Vaccinated:2011-08-30
Onset:2011-09-10
Submitted:2014-03-25
Entered:2014-03-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / - UNK UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Coeliac disease, Fatigue, Gait disturbance, Muscular weakness, Myalgia, Myasthenia gravis, Immunoglobulin therapy

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES1403USA010855

Write-up:This spontaneous report as received from a physician refers to a 16 year old female patient. On 30-AUG-2011 the patient was vaccinated with GARDASIL, 0.5 ml, intramuscular. The dose number, the lot number and expiration date of the vaccine, the route of administration and anatomical location of the vaccination were not reported. On 10-SEP-2011, reported as 11 days after the date of vaccination the patient experienced celiac disease (disability, medically significant upon internal review), tripping down the stairs because her legs were so weak (disability), muscle pain (disability), extreme fatigue (disability), myasthenia gravis (disability, medically significant upon internal review) and being so weak that she had issue lifting her arms (disability). Disability was reported as serious criterion, the event(s) to which this referred however were not specified. Treatment for the myasthenia gravis included MESTINON, IVIG and Prednisone. The outcome of celiac disease, tripping down the stairs, muscle pain, extreme fatigue and myasthenia gravis was reported as not recovered/not resolved. The physician reported that all adverse effects were progressing. No causality statement was reported for any of the events in relation to GARDASIL. Additional information has been requested.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=526572&WAYBACKHISTORY=ON


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166